Human transcription factor genes involved in neuronal development tend to have high GC content and CpG elements in the proximal promoter region

Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Institute of Neuroscience and The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China

More Information

Corresponding author: E-mail address: longys1972@yahoo.com.cn (Yue-Sheng Long)

摘要

- /
- /
- /
- /
Abstract: Transcription factors (TFs) play critical roles in the development of the nervous system, but the transcriptional regulatory mechanisms of these genes are poorly understood. Here we analyzed 5-kb of the 5′ flanking genomic DNA sequences of 41 TF genes involved in neuronal development. The results showed that the TF genes tend to have higher GC contents in the proximal region and most of the TF genes have at least one proximal GC-rich (GC content > 60%) promoter with a CpG island. The promoter distribution analysis showed that the GC-poor promoters were sporadically distributed within the 5-kb flanking genomic sequence (FGS); however, more than half (37 of 70) of the GC-rich promoters were located in the proximal region between nucleotides −1 and −500. Luciferase assays showed that partial GC-rich promoters increased gene expression in SH-SY5Y cells and that CpG methylation repressed the promoter activity. This study suggests a potential general mechanism for regulation of TF expression.
- Transcription factor /
- Promoter /
- GC content /
- CpG island /
- DNA methylation

HTML全文

参考文献(26)

[1]	Alberini, C.M. Transcription factors in long-term memory and synaptic plasticity Physiol. Rev., 89 (2009),pp. 121-145
[2]	Amir, R.E., Van den Veyver, I.B., Wan, M. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 Nat. Genet., 23 (1999),pp. 185-188
[3]	Antequera, F. Structure, function and evolution of CpG island promoters Cell. Mol. Life Sci., 60 (2003),pp. 1647-1658
[4]	Carney, R.M., Wolpert, C.M., Ravan, S.A. et al. Pediatr. Neurol., 28 (2003),pp. 205-211
[5]	Carninci, P., Sandelin, A., Lenhard, B. et al. Genome-wide analysis of mammalian promoter architecture and evolution Nat. Genet., 38 (2006),pp. 626-635
[6]	Chahrour, M., Jung, S.Y., Shaw, C. et al. MeCP2, a key contributor to neurological disease, activates and represses transcription Science, 320 (2008),pp. 1224-1229
[7]	Clayton-Smith, J., Watson, P., Ramsden, S. et al. Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males Lancet, 356 (2000),pp. 830-832
[8]	Cong, Y.S., Wen, J., Bacchetti, S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter Hum. Mol. Genet., 8 (1999),pp. 137-142
[9]	Couvert, P., Bienvenu, T., Aquaviva, C. et al. MECP2 is highly mutated in X-linked mental retardation Hum. Mol. Genet., 10 (2001),pp. 941-946
[10]	Groves, A.K., George, K.M., Tissier-Seta, J.P. et al. Differential regulation of transcription factor gene expression and phenotypic markers in developing sympathetic neurons Development, 121 (1995),pp. 887-901
[11]	Holler, M., Westin, G., Jiricny, J. et al. Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated Genes Dev., 2 (1988),pp. 1127-1135
[12]	Jones, P.A., Takai, D. The role of DNA methylation in mammalian epigenetics Science, 293 (2001),pp. 1068-1070
[13]	Jones, P.L., Veenstra, G.J., Wade, P.A. et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription Nat. Genet., 19 (1998),pp. 187-191
[14]	Koudritsky, M., Domany, E. Positional distribution of human transcription factor binding sites Nucleic Acids Res., 36 (2008),pp. 6795-6805
[15]	Lai, C.S., Fisher, S.E., Hurst, J.A. et al. A forkhead-domain gene is mutated in a severe speech and language disorder Nature, 413 (2001),pp. 519-523
[16]	Lander, E.S., Linton, L.M., Birren, B. et al. Initial sequencing and analysis of the human genome Nature, 409 (2001),pp. 860-921
[17]	Li, X., Madison, B.B., Zacharias, W. et al. Deconvoluting the intestine: molecular evidence for a major role of the mesenchyme in the modulation of signaling cross talk Physiol. Genomics, 29 (2007),pp. 290-301
[18]	Matys, V., Fricke, E., Geffers, R. et al. TRANSFAC: transcriptional regulation, from patterns to profiles Nucleic Acids Res., 31 (2003),pp. 374-378
[19]	Robertson, K.D., Hayward, S.D., Ling, P.D. et al. Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial Mol. Cell. Biol., 15 (1995),pp. 6150-6159
[20]	Ross, S.E., Greenberg, M.E., Stiles, C.D. Basic helix-loop-helix factors in cortical development Neuron, 39 (2003),pp. 13-25
[21]	Sandelin, A., Carninci, P., Lenhard, B. et al. Mammalian RNA polymerase II core promoters: insights from genome-wide studies Nat. Rev. Genet., 8 (2007),pp. 424-436
[22]	Shiota, K. DNA methylation profiles of CpG islands for cellular differentiation and development in mammals Cytogenet. Genome Res., 105 (2004),pp. 325-334
[23]	Solovyev, V., Salamov, A. The Gene-Finder computer tools for analysis of human and model organisms genome sequences Proc. Int. Conf. Intell. Syst. Mol. Biol., 5 (1997),pp. 294-302
[24]	Tabach, Y., Brosh, R., Buganim, Y. et al. Wide-scale analysis of human functional transcription factor binding reveals a strong bias towards the transcription start site PLoS ONE, 2 (2007),p. e807
[25]	Venter, J.C., Adams, M.D., Myers, E.W. et al. The sequence of the human genome Science, 291 (2001),pp. 1304-1351
[26]	Vinogradov, A.E. Dualism of gene GC content and CpG pattern in regard to expression in the human genome: magnitude versus breadth Trends Genet., 21 (2005),pp. 639-643